This particular one is mostly about dosing, the available medicines were weight based, with lowest dosages in the 5-15kg range. This brings dosages lower allowing more precise dosing for the lighter babies.
Edit: it's a very welcome addition. Limits side effects.
I heard this story on the radio last week, and the Italian physician working in Africa for a very long time said that the treatments have been provided for babies older than 6 months successfully. The new and important step (with Novartis) is to now safely treat babies younger than 6 months with the appropriate dosing. I wish I could find the link to the radio story.
China had been, until recently, for decades, the most populated country in the world. Still Chinese people don't have a problem called malaria. Why ?
Because they use a plant to prevent and heal it. I can't recall the name of this plant but I remember I saw a documentary stating that China tried multiple times to export that plant to the world but Bill Gates, who is interested in the subject and wanted to develop a vaccine for malaria, for a long time convinced the world health organization to not allow that on the name that the plant has health risks, inefficient and is dangerous to the environment.
It's a traditional medicine for malaria, and the reason china wasn't exporting it was due to the military importance of anti-malaria medicine. This was a thing before Bill Gates was rich or powerful. Since then, I'm not really aware of any suppression of the drug. The only anti-malaria treatment which has been suppressed by US interests is the vaccine, because they didn't believe it was profitable. Now that it is profitable, they're going forward with it.
Now that the white wormwood based treatment is known worldwide, there are questions about whether it should be kept in reserve like quinine. I'm not sure if things have changed, but I recall an approach is to give Artemisinin alongside another treatment, to prevent malaria from adapting. In africa, people will commonly listen to the doctor's instruction to take the whole course of medicine and will ignore it and just take half. They give the other half to a relative. This causes treatment resistant malaria to develop.
12 comments
[ 4.8 ms ] story [ 34.2 ms ] threadEdit: it's a very welcome addition. Limits side effects.
They did do a 12 month check-in which is good, but why such a small group of study participants, especially when malaria is so widespread?
[1] https://clinicaltrials.gov/study/NCT04300309?term=CALINA&ran...
Because they use a plant to prevent and heal it. I can't recall the name of this plant but I remember I saw a documentary stating that China tried multiple times to export that plant to the world but Bill Gates, who is interested in the subject and wanted to develop a vaccine for malaria, for a long time convinced the world health organization to not allow that on the name that the plant has health risks, inefficient and is dangerous to the environment.
Now that the white wormwood based treatment is known worldwide, there are questions about whether it should be kept in reserve like quinine. I'm not sure if things have changed, but I recall an approach is to give Artemisinin alongside another treatment, to prevent malaria from adapting. In africa, people will commonly listen to the doctor's instruction to take the whole course of medicine and will ignore it and just take half. They give the other half to a relative. This causes treatment resistant malaria to develop.